KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Receivables (2016 - 2025)

Historic Receivables for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $17.6 billion.

  • Johnson & Johnson's Receivables rose 888.46% to $17.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 billion, marking a year-over-year increase of 888.46%. This contributed to the annual value of $14.8 billion for FY2024, which is 20.84% down from last year.
  • Johnson & Johnson's Receivables amounted to $17.6 billion in Q3 2025, which was up 888.46% from $17.8 billion recorded in Q2 2025.
  • Over the past 5 years, Johnson & Johnson's Receivables peaked at $17.8 billion during Q2 2025, and registered a low of $13.6 billion during Q1 2021.
  • Moreover, its 5-year median value for Receivables was $15.4 billion (2022), whereas its average is $15.6 billion.
  • In the last 5 years, Johnson & Johnson's Receivables plummeted by 858.72% in 2024 and then skyrocketed by 1299.23% in 2025.
  • Johnson & Johnson's Receivables (Quarter) stood at $14.9 billion in 2021, then increased by 6.57% to $15.9 billion in 2022, then decreased by 6.4% to $14.9 billion in 2023, then dropped by 0.21% to $14.8 billion in 2024, then increased by 18.66% to $17.6 billion in 2025.
  • Its Receivables stands at $17.6 billion for Q3 2025, versus $17.8 billion for Q2 2025 and $16.0 billion for Q1 2025.